MiMedx Closes Acquisition of Stability Biologics

By Julie A. Vetalice

MiMedx completed its acquisition of Stability Biologics, provider of human tissue products serving the surgical, spine and orthopaedic sectors. Stability Biologics will operate as a wholly-owned subsidiary of MiMedx.

Source: MiMedx Group

MiMedx expects full-year 2016 revenues of at least $15MM generated from Stability Biologics' processed tissue and bone product distribution/sales.

Tags: M&A